Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma

NCT00079755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaplastic Large-Cell Lymphoma

Interventions

DRUG: SGN-30 (anti-CD30 mAb)

Sponsor

Seagen Inc.